Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'daiichi sankyo company, ltd - financial and strategic analysis review' returned 13 results - Page 1 of 1   Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Forest Laboratories: Pipeline - Products - Performance - Potential   Espicom Business Intelligence Ltd, Feb 2009, Pages: 66 ... Ltd - Cypress Bioscience Inc - Daiichi Sankyo - Gedeon Richter Ltd - Glenmark Pharmaceuticals Ltd - INO Therapeutics ... Pharma GmbH & Co KGaA - Microbia ... sanofi-aventis - Pipeline - Products - Performance - Potential   Espicom Business Intelligence Ltd, Sep 2009, Pages: 212 ... The companys financial performance is covered in ... Group Inc - Crucell NV - Daiichi Sankyo - Dainippon Sumitomo ... Taiho Pharmaceutical Co Ltd - Teva Pharmaceutical ... GE Healthcare Medical Device Company Intelligence Report   Espicom Business Intelligence Ltd, April 2009, Pages: 84 ... and geographic location Strategic Focus - Investigates the ... in-depth five year financial analysis. ... InSightec Image Guided Treatment Ltd - Daiichi Sankyo Co Ltd. GlaxoSmithKline: Pipeline, Products, Performance and Potential   Espicom Business Intelligence Ltd, Oct 2009, Pages: 290 ... full 5-year financial performance assessment ... Research - Cytokinetics Inc - Daiichi Sankyo - Dainippon Sumitomo ... Taiho Pharmaceutical Company Ltd - Tanabe - Teva ... Kyowa Hakko: Performance, Products, Pipeline and Potential   Espicom Business Intelligence Ltd, Aug 2009, Pages: 84 ... to companies such as Astellas and Daiichi Sankyo. ... review of the company's product portfolio ... Fabre - BioWa - Britannia Pharmaceuticals Limited - Cephalon Inc ... Prescription Drugs - Global Strategic Business Report   Global Industry Analysts, Inc., July 2009, Pages: 1810 ... 110 Forest and Daiichi Sankyo Sign Contract ... 51: Leading Pharmaceutical Companies in Japan ... Pharmaceuticals, Astellas Seiyaku, Dai-ichi Sankyo, Mitsubishi Tanabe ... The Indian Pharmaceutical Industry 2009: Diversification, Expansion & Ambitions   Espicom Business Intelligence Ltd, May 2009, Pages: 250 ... Key Markets Major Developments Daiichi Sankyo acquires Ranbaxy ... Pinewood Laboratories CP Pharmaceuticals Ltd Agreements & ... market and the 18 companies that are ... UK IFAs 2007   Datamonitor, Oct 2007, Pages: 91 ... Ltd City Holding Company Computer Task Group, Incorporated Cyclacel Pharmaceuticals, Inc. Cytogen Corporation Daiichi Sankyo, Ltd. ... Point of Care Diagnostic Testing Sector Trends   TriMark Publications, June 2009, Pages: 160 ... Testing 47 4.3.1 The Financial Advantages of POCT ... Systems - Cytogen - Dade Behring - Daiichi Sankyo Group - Denka Seiken Co-, Ltd- - Diagnostic Chemicals ... Bayer: Performance, Products, Pipeline and Potential   Espicom Business Intelligence Ltd, Oct 2009, Pages: 172 ... Breakdown 13 Company Strategy 17 Research and ... Cytogen Corporation - Daiichi Sankyo - DARA Biosciences ... Ranbaxy Laboratories Limited - Regeneron Pharmaceuticals ... Success Stories: Japan   Success Stories Media ... Dai-Ichi Kosho - Dai-Ichi Mutual Life ... Sankei Company - Sankyo Company - San Nopco ... Synovus Financial - SystemSoft - Tachikara - Taisei Company - Taisho Life ... Pharmaceutical Pricing and Distribution in Japan: The keys to success in the world’s second largest market   Just Pharma Reports, June 2008, Pages: 110 ... If the company does not accept DPO?s ... diagnosis procedure combinations, is limited to acute ... Boehringer Ingelheim BMS Chugai Daiichi-Sankyo Dainippon Sumitomo ... Injectable Generic Drugs: Prospects & Opportunities to 2013   Espicom Business Intelligence Ltd, July 2008, Pages: 264 ... & Sali Healthcare 223 NCPC Orchid Pharmaceuticals Ltd 223 Paddock ... McNeil (J&J) in the US, by Daiichi Sankyo as Cravit ... as Tavanic; and Merck & Co?s antifungal ... No more results

		Top of page

All rights reserved. © Copyright 2009 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster